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Background: Following percutaneous aortic endoprosthesis implantation, fever was observed in 30-60% of patients. In our preliminary experience, 
a similar pattern was observed after transcatheter aortic valve implantation (TAVI). The aim of our study was to evaluate the incidence of fever after 
TAVI and to assess if the phenomenon was due to infection or an inflammatory response.
Methods: All consecutive patients undergoing TAVI from 2007-2010 using all available routes were analyzed. In all patients, blood samples 
including full blood count, biochemical profile and C-Reactive Protein (CRP) were measured. In addition, patients with fever had a full septic screen 
including blood, urine and sputum culture as well as relevant radiologic examinations. All patients with fever were given empirical antibiotics.
Results: 191 patients were included. 83 (43%) had fever after TAVI. Mean age was 79.6±7.2 years and logistic EuroSCORE 25.8±17.1%. Sixty 
(31.4%) patients were diabetics and 72 (37.7%) had chronic kidney disease. Edwards SAPIEN™ was implanted in 123 (64.0%) patients, Medtronic 
CoreValve ReValving System® in 68 (34%). Most of them (n=55, 66%) had fever without bacteriological or radiological evidence of infection; 
conversely 28 (34%) had fever with a documented infection. In the first group, 65% developed fever within 24-hours of the procedure: temperature 
38.18±0.6°C, duration 2.43±1.6 days. In these patients an inflammatory status was detected (white blood count was 12.2±4.9x109/l and CRP 
was 129.8±57.9 mg/l). In the second group, 50% patients developed fever within 24-hours from the procedure: temperature 38.3±0.9°C, duration 
4.6±7.6 days, increase in white blood count (15.8±7.06x109/l) and in CRP (150.8±78 mg/l). In these patients, the source of infection was 
respiratory in 50.5%; urinary in 25.0%, access site 14.0%, bacterial endocarditis in 3.5%, positive blood cultures without an overt focus in 11.0%.
Conclusions: In our experience, 43% of the patients undergoing TAVI developed a fever within 24-hours of the procedure. Most patients with fever 
had an evidence of an acute inflammatory response in the absence of documented infection.
